Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 4
Submit an article Journal homepage
232
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia*

Matt E. KalaycioCleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA,
,
O. George NegreaLow Country Cancer Care Associates, Savannah, GA, USA,
,
Steven L. AllenHofstra North Shore – LIJ School of Medicine, Lake Success, NY, USA,
,
Kanti R. RaiHofstra North Shore – LIJ School of Medicine, Lake Success, NY, USA,
,
Rashid M. AbbasiHematology Oncology Specialists, Denville, NJ, USA, and
,
Heather HorneImmunomedics, Inc., Morris Plains, NJ, USA
,
William A. WegenerImmunomedics, Inc., Morris Plains, NJ, USA
&
David M. GoldenbergImmunomedics, Inc., Morris Plains, NJ, USACorrespondence[email protected]
 show all
Pages 803-811 | Received 19 Jun 2015, Accepted 17 Aug 2015, Published online: 19 Oct 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jennifer L. Crombie & Jennifer R. Brown. (2021) The future of antibody therapy in chronic lymphocytic leukemia. Expert Opinion on Emerging Drugs 26:3, pages 323-336.
Read now
Wade Chun-Wai Suen, Wayne Yuk-Wai Lee, Kam-Tong Leung, Xiao-Hua Pan & Gang Li. (2018) Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials. Cancer Investigation 36:8, pages 431-457.
Read now
Mitchell Evers, Margot Jak & J. H. W. Leusen. (2018) The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 18:9, pages 973-982.
Read now
Irene Moreno Torres & Antonio García-Merino. (2017) Anti-CD20 monoclonal antibodies in multiple sclerosis. Expert Review of Neurotherapeutics 17:4, pages 359-371.
Read now

Articles from other publishers (7)

Konstantin Dobrenkov & Nai-Kong V. Cheung. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 486 499.e8 .
Smita Y. Patel, Javier Carbone & Stephen Jolles. (2019) The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management. Frontiers in Immunology 10.
Crossref
Luis Mario Villela-Ma, Ana Karen Velez-Ayal, Rosa del Carmen Lopez-Sanc, Jorge A Martinez-C & Jose A Hernandez-. (2017) Advantages of Drug Selective Distribution in Cancer Treatment: Brentuximab Vedotin. International Journal of Pharmacology 13:7, pages 785-807.
Crossref
L.A. Butler, C.S. Tam & J.F. Seymour. (2017) Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era. Blood Reviews 31:5, pages 318-327.
Crossref
Maria Carmen Ochoa, Luna Minute, Inmaculada Rodriguez, Saray Garasa, Elisabeth Perez‐Ruiz, Susana Inogés, Ignacio Melero & Pedro Berraondo. (2017) Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells. Immunology & Cell Biology 95:4, pages 347-355.
Crossref
David J. M. Routledge & Adrian J. C. Bloor. (2016) Recent advances in therapy of chronic lymphocytic leukaemia. British Journal of Haematology 174:3, pages 351-367.
Crossref
Carin I. M. Dahlberg, Dhifaf Sarhan, Michael Chrobok, Adil D. Duru & Evren Alici. (2015) Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity. Frontiers in Immunology 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.